[Cimifugin ameliorates Crohn's disease-like colitis in mice by modulating Th-cell immune balance <i>via</i> inhibiting the MAPK pathway].
Cimifugin alleviates TNBS-induced CD-like colitis by repairing intestinal barrier damage and restoring Th1/Th2 and Th17/Treg balance via suppressing MAPK pathway activation.
Authors
- Zhijun Geng (ORCID: https://orcid.org/0000-0002-4040-5622)
- Keni Zhang
- Meng Niu (ORCID: https://orcid.org/0000-0003-1055-3728)
- Jiangyan Li (ORCID: https://orcid.org/0000-0002-2038-983X)
- Jianguo Hu (ORCID: https://orcid.org/0000-0002-9832-6951)
- Lixia Yin (ORCID: https://orcid.org/0009-0005-6852-5713)
- Jing Li (ORCID: https://orcid.org/0000-0002-8030-7146)
Institutions
- Bengbu Medical College (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-03-20
- DOI
- https://doi.org/10.12122/j.issn.1673-4254.2025.03.17
- Primary Topic
- Nigella sativa pharmacological applications
- Type
- article